Michael Fine, DPM
Podiatrist · N Kansas City, MONPI 1033147277
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $284 of the $396 with a category attached, or 71.7%. 6 manufacturers reported payments, led by Organogenesis Inc. at 40.1% of the total. 2025 is the largest year on record at $112, 3.7 times the $31 reported in 2019. That places this record below the midpoint for podiatrist clinicians in MO, where the typical reported total is $1,070.
Across 14 payments — averaging $28.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$159
- DJO, LLC$112
- Nevro Corp.$56
- Zimmer Biomet$25
- Bioventus LLC$23
- Saluda Medical Americas, Inc.$21
What the payments were for
- Food & beverage$28472%
- Education$11228%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 6 | $159 |
| DJO, LLC | 2 | $112 |
| Nevro Corp. | 2 | $56 |
| Zimmer Biomet | 2 | $25 |
| Bioventus LLC | 1 | $23 |
| Saluda Medical Americas, Inc. | 1 | $21 |
How this compares
$396 in reported general payments places this provider in the 30th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 60 | $1,672 |
| Cephalexin | 58 | $321 |
| Gabapentin | 57 | $303 |
| Doxycycline Hyclate | 37 | $289 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in N Kansas City
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
- Ellen ColganWarrenton$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.